ImpediMed logo

IPD - ImpediMed Share Price

A$0.155 0.0  0.0%

Last Trade - 6:10am

Sector
Healthcare
Size
Micro Cap
Market Cap £41.8m
Enterprise Value £35.8m
Revenue £2.20m
Position in Universe 737th / 1837
Bullish
Bearish
Unlock IPD Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

IPD Revenue Unlock IPD Revenue

Net Income

IPD Net Income Unlock IPD Revenue

Normalised EPS

IPD Normalised EPS Unlock IPD Revenue

PE Ratio Range

IPD PE Ratio Range Unlock IPD Revenue

Dividend Yield Range

IPD Dividend Yield Range Unlock IPD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
IPD EPS Forecasts Unlock IPD Revenue
Profile Summary

ImpediMed Limited is an Australia-based company, which is a global provider of medical technology to measure, monitor and manage fluid status and body composition. The principal activities of the Company consist of the development, manufacture and sale of bioimpedance instruments and consumables, and the sale of electronic test and measurement devices. The Company's operating segments include Medical, and Test & Measurement. The Medical segment is a supplier of non-invasive medical devices to over two underserved markets: aiding in the subclinical assessment of individuals at risk of secondary lymphedema, and the monitoring of body composition and hydration. The medical cash-generating unit (CGU) is the core business of the Company. The Test & Measurement segment is a supplier of power precision testing and measuring equipment (T&M). The Company's geographical locations include Australia/rest of world (ROW) and North America.

Directors
Last Annual June 30th, 2019
Last Interim June 30th, 2019
Incorporated September 27, 1999
Public Since October 24, 2007
No. of Shareholders: 4,503
No. of Employees: 67
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 509,771,494
Free Float (0.0%)
Eligible for
ISAs
SIPPs
IPD Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for IPD
Upcoming Events for IPD
Similar to IPD
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.